• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer.

作者信息

Hossain K R, Escobar Bermeo J D, Warton K, Valenzuela S M

机构信息

School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.

ARC Research Hub for Integrated Device for End-user Analysis at Low-levels (IDEAL), Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.

出版信息

Front Bioeng Biotechnol. 2022 Feb 10;10:819183. doi: 10.3389/fbioe.2022.819183. eCollection 2022.

DOI:10.3389/fbioe.2022.819183
PMID:35223789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8867026/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba4e/8867026/74d27f7a725c/fbioe-10-819183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba4e/8867026/74d27f7a725c/fbioe-10-819183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba4e/8867026/74d27f7a725c/fbioe-10-819183-g001.jpg

相似文献

1
New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer.卵巢癌早期检测的新方法及生物标志物候选物
Front Bioeng Biotechnol. 2022 Feb 10;10:819183. doi: 10.3389/fbioe.2022.819183. eCollection 2022.
2
Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.与用于生物标志物开发的外泌体分离相关的技术：用于卵巢癌检测的液体活检
Methods Mol Biol. 2020;2055:181-199. doi: 10.1007/978-1-4939-9773-2_8.
3
Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells.卵巢癌细胞和卵巢表面上皮细胞来源的外泌体的蛋白质组学和脂质组学分析。
J Ovarian Res. 2020 Jan 22;13(1):9. doi: 10.1186/s13048-020-0609-y.
4
Multi-biomarker panel signature as the key to diagnosis of ovarian cancer.多生物标志物组合特征作为卵巢癌诊断的关键
Heliyon. 2019 Dec 5;5(12):e02826. doi: 10.1016/j.heliyon.2019.e02826. eCollection 2019 Dec.
5
Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer.检测外泌体酪氨酸受体激酶 B 作为卵巢癌的潜在生物标志物。
J Cell Biochem. 2019 Apr;120(4):6361-6369. doi: 10.1002/jcb.27923. Epub 2018 Oct 10.
6
[Molecular diagnostics of ovarian cancer using proteome techniques].[利用蛋白质组技术进行卵巢癌的分子诊断]
Biomed Khim. 2005 Jul-Aug;51(4):367-83.
7
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.卵巢癌女性外周循环中含紧密连接蛋白的外泌体。
BMC Cancer. 2009 Jul 20;9:244. doi: 10.1186/1471-2407-9-244.
8
Exosomal Aβ-Binding Proteins Identified by "In Silico" Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease.通过“计算机分析”鉴定的外泌体 Aβ 结合蛋白代表阿尔茨海默病潜在的血源性生物标志物候选物。
Int J Mol Sci. 2021 Apr 11;22(8):3933. doi: 10.3390/ijms22083933.
9
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.激肽释放酶家族蛋白酶KLK6和KLK7是浆液性和乳头状浆液性卵巢癌亚型潜在的早期检测和诊断生物标志物。
J Ovarian Res. 2014 Dec 5;7:109. doi: 10.1186/s13048-014-0109-z.
10
The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.丝氨酸蛋白酶前列腺素（PRSS8）是早期检测卵巢癌的潜在生物标志物。
J Ovarian Res. 2016 Mar 31;9:20. doi: 10.1186/s13048-016-0228-9.

引用本文的文献

1
Plasmonic Mesoporous Gold-Based SERS Biosensor for Ovarian Cancer-Derived Extracellular Vesicles.用于卵巢癌衍生细胞外囊泡的等离子体介孔金基表面增强拉曼散射生物传感器
Small. 2025 Aug;21(34):e2401817. doi: 10.1002/smll.202401817. Epub 2025 Jul 9.
2
Genomic and clinical insights into ovarian cancer: subtype-specific alterations and predictors of metastasis and relapse.卵巢癌的基因组与临床见解：亚型特异性改变以及转移和复发的预测因素
Discov Oncol. 2025 May 24;16(1):907. doi: 10.1007/s12672-025-02725-7.
3
Promising new drugs and therapeutic approaches for treatment of ovarian cancer-targeting the hallmarks of cancer.

本文引用的文献

1
Identification of chloride intracellular channels as prognostic factors correlated with immune infiltration in hepatocellular carcinoma using bioinformatics analysis.利用生物信息学分析鉴定氯离子细胞内通道作为与肝癌免疫浸润相关的预后因素。
Medicine (Baltimore). 2021 Nov 12;100(45):e27739. doi: 10.1097/MD.0000000000027739.
2
Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications.卵巢癌相关细胞外囊泡：微环境调控及潜在临床应用。
Cells. 2021 Sep 1;10(9):2272. doi: 10.3390/cells10092272.
3
Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications.
治疗卵巢癌的有前景的新药和治疗方法——针对癌症的特征
BMC Med. 2025 Jan 6;23(1):10. doi: 10.1186/s12916-024-03826-w.
4
Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers.用于检测卵巢癌生物标志物的表面等离子体共振（SPR）技术的最新进展
Cancers (Basel). 2023 Nov 27;15(23):5607. doi: 10.3390/cancers15235607.
5
New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases.靶向卵巢癌腹膜转移中重新布线的脂质代谢的 Ferroptosis 起始治疗（FIT）的新见解。
Int J Mol Sci. 2022 Dec 3;23(23):15263. doi: 10.3390/ijms232315263.
6
Extracellular biogenesis, isolation, manipulation and genetic engineering for potential and therapeutics: An overview.用于潜在应用和治疗的细胞外生物合成、分离、操作及基因工程：综述。
Front Bioeng Biotechnol. 2022 Nov 4;10:1019821. doi: 10.3389/fbioe.2022.1019821. eCollection 2022.
外泌体作为诊断生物标志物和靶向药物递送的潜在用途：临床前和临床应用的进展。
ACS Biomater Sci Eng. 2021 Jun 14;7(6):2106-2149. doi: 10.1021/acsbiomaterials.1c00217. Epub 2021 May 14.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development.癌症来源的外泌体：它们在癌症生物学和生物标志物开发中的作用。
Int J Nanomedicine. 2020 Oct 19;15:8019-8036. doi: 10.2147/IJN.S272378. eCollection 2020.
6
amplified QCM immunoassay for carcinoembryonic antigen with colorectal cancer using horseradish peroxidase nanospheres and enzymatic biocatalytic precipitation.基于辣根过氧化物酶纳米球和酶催化生物沉淀的大肠癌癌胚抗原放大 QCM 免疫分析
Analyst. 2020 Sep 14;145(18):6111-6118. doi: 10.1039/d0an01399d.
7
A review on impedimetric immunosensors for pathogen and biomarker detection.基于阻抗的免疫传感器用于病原体和生物标志物检测的研究进展综述。
Med Microbiol Immunol. 2020 Jun;209(3):343-362. doi: 10.1007/s00430-020-00668-0. Epub 2020 Apr 3.
8
Intracellular Chloride Channels: Novel Biomarkers in Diseases.细胞内氯离子通道：疾病中的新型生物标志物
Front Physiol. 2020 Feb 14;11:96. doi: 10.3389/fphys.2020.00096. eCollection 2020.
9
MicroRNAs in ovarian cancer and recent advances in the development of microRNA-based biosensors.卵巢癌中的 microRNAs 及基于 microRNA 的生物传感器的最新进展。
Analyst. 2020 Mar 21;145(6):2038-2057. doi: 10.1039/c9an02263e. Epub 2020 Feb 4.
10
Acoustic Immunosensing of Exosomes Using a Quartz Crystal Microbalance with Dissipation Monitoring.利用石英晶体微天平耗散监测技术对细胞外囊泡进行声学免疫传感。
Anal Chem. 2020 Mar 3;92(5):4082-4093. doi: 10.1021/acs.analchem.9b05736. Epub 2020 Feb 13.